# Implantation or Injectable Dosage Form New Animal Drugs; Sometribove Zinc Suspension
> **Food and Drug Administration** · Final rule; technical amendment. · Published 2003-10-31 · Effective 2003-10-31 · 68 FR 62005
## Document
- **Document number:** 03-27395
- **Category:** fda-drug
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 62005
- **CFR reference:** 21 CFR 510
- **Publication date:** 2003-10-31
- **Effective date:** 2003-10-31
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Monsanto Co. The supplemental NADA provides for revised wording of the indication and precautionary labeling for sometribove zinc suspension used to increase the production of marketable milk in healthy lactating dairy cows. The regulations are also being amended to reflect a different drug labeler code (DLC) for Monsanto Co.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/10/31/03-27395/implantation-or-injectable-dosage-form-new-animal-drugs-sometribove-zinc-suspension)
---
*AI Analytics · CC0 1.0*